Thermo Fisher Scientific Bioproduction Articles
-
Improve Productivity In CHO-K1, CHO-S, And DG44 Cells
4/18/2022
This commercially available platform can enhance process productivity and reduce development time, thereby enabling potential reductions in manufacturing costs and accelerating time-to-market.
-
Single-Use Solutions For Research And Process Development
4/12/2022
Can supply chain assurance be maintained while offering an array of possibilities to achieve complex process designs? Learn if you could benefit from a modularized, standardized single-use manifold design.
-
Reducing Risk During CAR T Cell Therapy Development And Manufacture
1/26/2022
It is essential to identify potential areas for optimization early in CAR T cell therapy development—particularly with respect to equipment, reagents, and analytics.
-
Diploid Serum-Reduced Medium System Supports Viral Production
10/21/2021
Results demonstrate that the system can enable vaccine manufacturers to reduce the use of FBS while achieving potential increases in viral specific productivity with diploid cells.
-
Reduce Or Eliminate Serum Use In Vaccine Production
10/21/2021
The use of this Diploid Growth Serum-Reduced Medium (SRM) helps vaccine manufacturers using diploid cells meet their production forecasts while reducing production costs and serum use.
-
Optimize Allogeneic Workflow, Cell Proliferation
8/17/2021
This application note outlines the capabilities of CTS OpTmizer Pro SFM compared with a control medium in both diseased patients’ and healthy donors’ cells.
-
Human Regulatory T Cell Expansion And Measurement Of Function
8/17/2021
Regulatory T cells (Tregs) are a subpopulation of T cells with the unique ability to suppress the activation of effector T cells and thereby prevent T cell function. This application note describes an optimized protocol for activation and expansion of flow-sorted Tregs with Gibco™ CTS™ Dynabeads™ Treg Xpander.
-
Bacto CD Supreme FPM Consistently Supports Higher Growth And Plasmid Production In E. coli
8/12/2021
Traditional microbial media for E. coli often contain animal-origin components and are complex. Stemmed from an overall industry drive to develop animal origin–free (AOF) and chemically defined (CD) media, Gibco™ Bacto™ CD Supreme Fermentation Production Medium (FPM) supports process flexibility and consistency in production. Read the results of a head-to-head comparison between Bacto CD Supreme FPM and Terrific Broth (TB), a traditional microbial medium.
-
One-Step Isolation And Activation Of Naive And Early Memory T Cells With CTS Dynabeads CD3/CD28
7/6/2021
In this application note we demonstrate nearly 100% recovery of naive and early memory T cells using Gibco™ CTS™ Dynabeads™ CD3/CD28 beads. This one-step process of simultaneous T cell isolation and activation yields pure and uniformly activated T cells.
-
Understanding Perfusion Terminology
6/7/2021
To evaluate whether a perfusion application will work in a production process, standardized terminology is critical. This white paper explains key terms that are essential for understanding the process.